epigallocatechin gallate has been researched along with Rodent Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, JH; Jo, HH; Kim, DH; Kim, DJ; Kim, EY; Kim, HJ; Lee, BJ; Lee, HJ; Lee, SH; Nam, SY; Park, YS; Seok, JH | 1 |
| Kang, JB; Koh, PO; Park, DJ | 1 |
2 other study(ies) available for epigallocatechin gallate and Rodent Diseases
| Article | Year |
|---|---|
Epigallocatechin-3-gallate suppresses hemin-aggravated colon carcinogenesis through Nrf2-inhibited mitochondrial reactive oxygen species accumulation.
Topics: Animals; Antioxidants; Azoxymethane; Caco-2 Cells; Carcinogenesis; Catechin; Cell Cycle Proteins; Colon; Dextrans; Hemin; Humans; Iron; Kelch-Like ECH-Associated Protein 1; Lactate Dehydrogenases; Malondialdehyde; Mice; NF-E2-Related Factor 2; Reactive Oxygen Species; Rodent Diseases; Tea; Tetrazolium Salts | 2022 |
Identification of regulated proteins by epigallocatechin gallate treatment in an ischemic cerebral cortex animal model: a proteomics approach.
Topics: Animals; Catechin; Cerebral Cortex; Disease Models, Animal; Infarction, Middle Cerebral Artery; Proteomics; Rats; Rats, Sprague-Dawley; Rodent Diseases | 2021 |